LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.85 | 17.25 | 6080 | 5861 | 1.0373 | 1.0087 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.82 | 17.25 | 30 | 5924 | 0.0051 | 0.0679 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.82 | 17.25 | 6163 | 5924 | 1.0403 | 1.0094 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.82 | 17.25 | 10 | 5924 | 0.0017 | -0.0627 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.82 | 17.25 | 6037 | 5924 | 1.0191 | 1.0045 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.82 | 17.25 | 994 | 5924 | 0.1678 | 0.6181 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.82 | 17.25 | 6280 | 5924 | 1.0601 | 1.0139 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.79 | 17.25 | 3 | 6008 | 0.0005 | -0.1871 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.79 | 17.25 | 6333 | 6008 | 1.0540 | 1.0125 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.79 | 17.25 | 2 | 6008 | 0.0003 | -0.2252 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.79 | 17.25 | 6271 | 6008 | 1.0437 | 1.0102 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.79 | 17.25 | 935 | 6008 | 0.1556 | 0.6045 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.79 | 17.25 | 6427 | 6008 | 1.0697 | 1.0160 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.76 | 17.25 | 28 | 6047 | 0.0046 | 0.0590 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.76 | 17.25 | 6427 | 6047 | 1.0627 | 1.0144 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.76 | 17.25 | 5 | 6047 | 0.0008 | -0.1363 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.76 | 17.25 | 6462 | 6047 | 1.0685 | 1.0157 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.76 | 17.25 | 452 | 6047 | 0.0747 | 0.4716 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 88.76 | 17.25 | 6643 | 6047 | 1.0984 | 1.0223 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.74 | 17.25 | 24 | 6109 | 0.0039 | 0.0398 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.74 | 17.25 | 6591 | 6109 | 1.0788 | 1.0180 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.74 | 17.25 | 7 | 6109 | 0.0011 | -0.1010 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.74 | 17.25 | 6683 | 6109 | 1.0939 | 1.0213 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.74 | 17.25 | 501 | 6109 | 0.0820 | 0.4886 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 90.74 | 17.25 | 6815 | 6109 | 1.1155 | 1.0260 | MN20160310_N02 | K06 |